EditorialAggressive polyps in hereditary nonpolyposis colorectal cancer: Targets for screening
References (20)
- et al.
Mutations of a MutS homolog in hereditary non-polyposis colorectal cancer
Cell
(1993) - et al.
Genetics, natural history, tumor spectrum, and pathology of hereditary non-polyposis colorectal cancer: an updated review
Gastroenterology
(1993) Frequency of hereditary colorectal carcinoma
Gastroenterology
(1987)- et al.
Screening reduces colorectal cancer rate in hereditary non-polyposis colorectal cancer (HNPCC) families
Gastroenterology
(1995) - et al.
Screening for hereditary non-polyposis colorectal cancer
- et al.
Mutation of a mutL homolog in hereditary colon cancer
Science
(1994) - et al.
Mutation in the DNA mismatch repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer
Nature
(1994) - et al.
Mutations of two PMS homologues in hereditary non-polyposis colon cancer
Nature
(1994) - et al.
How prevalent is cancer family syndrome?
Gut
(1991) - et al.
The International Collaborative Group on hereditary non-polyposis colorectal cancer
Dis Colon Rectum
(1991)
Cited by (33)
Rapid Development of Colorectal Neoplasia in Patients With Lynch Syndrome
2011, Clinical Gastroenterology and HepatologyCitation Excerpt :In sporadic colorectal cancer, this period is considered, from a variety of sources but more from expert opinion, to be about 10 years.13 In LS, the polyp dwell time is estimated to be much shorter8,14,15 but has never been calculated. Nevertheless, screening and surveillance guidelines recommend colonoscopy every 1–2 years starting at age 20–25 and then annually after 40 years old.9
Colonic Polyps and Polyposis Syndromes
2010, Sleisenger and Fordtran’s Gastrointestinal and Liver Disease- 2 Volume Set: Pathophysiology, Diagnosis, Management, Expert Consult Premium Edition - Enhanced Online Features and PrintAltered DNA Mismatch Repair Expression in Synchronous and Metachronous Colorectal Cancers
2008, Clinical Gastroenterology and HepatologyCitation Excerpt :Such within-patient tumor heterogeneity might influence treatment strategies.15–17 Some have suggested that CRCs with DNA MMR or microsatellite instability represent a more aggressive subset and exhibit an accelerated adenoma-to-carcinoma progression.2,18 Given this natural history, it follows that such CRCs might more commonly emerge as interval cancers between scheduled surveillance examinations and account for a disproportionate number of metachronous CRCs.
Chromoendoscopic colonoscopy for detecting preneoplastic lesions in hereditary nonpolyposis colorectal cancer syndrome
2005, Clinical Gastroenterology and HepatologyDiagnosis and management of hereditary non-polyposis colon cancer
2003, Gastrointestinal Endoscopy